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Patients with clinically metabolically healthy obesity are not necessarily healthy 
subclinically: further support for bariatric surgery in patients without metabolic 
disease? 
ABSTRACT 
Background: Nonalcoholic fatty liver disease (NAFLD) increases the risk of liver cirrhosis 
and hepatocellular carcinoma and is also strongly correlated with extrahepatic diseases, 
including cardiovascular disease and type 2 diabetes. This risk of NAFLD among obese 
individuals who are otherwise metabolically healthy is not well characterized. Objectives: To 
determine the prevalence and characteristics of NAFLD in individuals with metabolically 
healthy obesity. Setting: A tertiary, academic, referral hospital. Methods: All patients who 
underwent bariatric surgery with intraoperative liver biopsy from 2008 to 2015 were 
identified. Patients with preoperative hypertension, dyslipidemia, or prediabetes/diabetes 
were excluded to identify a cohort of metabolically healthy obesity patients. Liver biopsy 
reports were reviewed to determine the prevalence of NAFLD. Results: A total of 270 
patients (7.0% of the total bariatric surgery patients) met the strict inclusion criteria for 
metabolically healthy obesity. The average age was 38 ± 10 years and the average body mass 
index was 47 ± 7 kg/m2. Abnormal alanine aminotransferase (>45 U/L) and asparate 
aminotransferase levels (>40 U/L) were observed in 28 (10.4%) and 18 (6.7%) patients, 
respectively. A total of 96 (35.5%) patients had NAFLD with NALFD Activity Scores 0 to 2 
(n = 61), 3 to 4 (n = 25), and 5 to 8 (n = 10). A total of 62 (23%) patients had lobular 
inflammation, 23 (8.5%) had hepatocyte ballooning, 22 (8.2%) had steatohepatitis, and 12 
(4.4%) had liver fibrosis. Conclusion: Even with the use of strict criteria to eliminate all 
patients with any metabolic problems, a significant proportion of metabolically healthy 
patients had unsuspected NAFLD. The need and clinical utility of routine screening of obese 
patients for fatty liver disease and the role of bariatric surgery in the management of NAFLD 
warrants further investigation. 
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